Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Pharma Foods International Co., Ltd.. A complete text table follows the diagram.
NEMO and new health products expanded consumer revenue, but advertising and inventory absorbed the economics while BtoB and biotech supplied the longer runway.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| B to C | 1 | 28.7B | 88.6% of reported total |
| B to B | 1 | 3.6B | 11.0% of reported total |
| Bio Medical | 1 | 104M | 0.3% of reported total |
| Other operating segments | 1 | 30M | 0.1% of reported total |
| Other & rounding | 1 | 1M | 0.0% of reported total |
| Revenues From External Customers | 2 | 32.4B | Reported six-month total · ¥32.4B |
| Operating loss | 2 | 2.4B | Absolute value of reported operating loss |
| Operating costs & expenses | 3 | 34.8B | Revenue plus reported operating loss |
| From | To | Value |
|---|---|---|
| B to C | Revenues From External Customers | 28.7B |
| B to B | Revenues From External Customers | 3.6B |
| Bio Medical | Revenues From External Customers | 104M |
| Other operating segments | Revenues From External Customers | 30M |
| Other & rounding | Revenues From External Customers | 1M |
| Revenues From External Customers | Operating costs & expenses | 32.4B |
| Operating loss | Operating costs & expenses | 2.4B |